Workflow
Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership
CICigna(CI) ZACKS·2025-01-30 18:45

Core Viewpoint - Cigna Group reported mixed financial results for the fourth quarter of 2024, with adjusted earnings per share (EPS) missing estimates while revenues showed significant growth year over year [1][2]. Financial Performance - Adjusted EPS for Q4 2024 was 6.64,missingtheZacksConsensusEstimateby15.26.64, missing the Zacks Consensus Estimate by 15.2%, and declined 2.2% year over year [1]. - Adjusted revenues increased by 28.4% year over year to 65.7 billion, surpassing the consensus mark by 3.9% [2]. - Total benefits and expenses rose 29% year over year to 63.5billion,drivenbyhigherpharmacyandmedicalcosts[4].Adjustedoperatingincomefell863.5 billion, driven by higher pharmacy and medical costs [4]. - Adjusted operating income fell 8% year over year to 1.8 billion, primarily due to reduced contributions from the Cigna Healthcare unit [4]. Customer Base and Segments - Cigna's medical customer base decreased by 3.2% year over year to 19.15 million, falling short of the consensus estimate [3]. - Evernorth Health Services segment reported adjusted revenues of 53.7billion,a3353.7 billion, a 33% increase year over year, exceeding the consensus estimate of 51.1 billion [5]. - Cigna Healthcare segment's adjusted revenues grew 3% year over year to 13.3billionbutmissedtheconsensusestimate[7].CostandMarginAnalysisTheadjustedpretaxmarginforoperatingincomedeterioratedby70basispointsyearoveryearto413.3 billion but missed the consensus estimate [7]. Cost and Margin Analysis - The adjusted pre-tax margin for operating income deteriorated by 70 basis points year over year to 4% [6]. - The medical care ratio (MCR) was reported at 87.9%, worsening by 570 basis points year over year due to increased stop-loss medical costs [8]. Financial Position - As of December 31, 2024, Cigna had cash and cash equivalents of 7.6 billion, a decrease of 3.5% from the previous year [9]. - Total assets increased by 2% to 155.9billion,whiletotalshareholdersequitydecreasedby11.2155.9 billion, while total shareholders' equity decreased by 11.2% to 41 billion [9]. Capital Deployment - Cigna repurchased 20.9 million shares for approximately 7billionin2024andincreaseditssharerepurchaseauthorizationto7 billion in 2024 and increased its share repurchase authorization to 10.3 billion [12]. - An 8% increase in the quarterly cash dividend was approved, raising it to 1.51pershare[12].2025OutlookAdjustedrevenuesfor2025areprojectedtobeatleast1.51 per share [12]. 2025 Outlook - Adjusted revenues for 2025 are projected to be at least 252 billion, indicating a minimum growth of 2% from 2024 [13]. - Adjusted operating income is expected to be a minimum of 7.9billion,reflectingagrowthofatleast2.17.9 billion, reflecting a growth of at least 2.1% from 2024 [13]. - The forecasted adjusted EPS for 2025 is a minimum of 29.50, suggesting a growth of at least 7.9% from 2024 [13].